Belgium: Defensive actions in UPC and national courts

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Belgium: Defensive actions in UPC and national courts

The opt‐out possibility offered by Article 83 UPCA pays lots of attention to the choices patentees are facing with regards to their filing strategy. We focus here on defensive strategies in the new legislative framework, in particular on actions before national courts.

Coexistence between the UPC and national jurisdictions during the transitional period is governed by the UPCA and by the Brussels Regulation (Recast) (EU) 1215/2012.

Article 83.3 UPCA establishes the right to opt‐out (completely) of the UPC.

Article 83.4 UPCA further stipulates that unless an action has already been brought before a national court, proprietors of or applicants for European patents who made use of the opt‐out in accordance with paragraph 3 shall be entitled to withdraw their opt‐out at any moment.

Thus, if an invalidity action before a national court exists, patentees will not be able to use the UPC at all, including an infringement action.

Is such a legal effect compatible with the Brussels Regulation? Not sure. It is true that under the Regulation, the court first seized retains jurisdiction when the same action, involving the same parties, is subsequently filed in another EU court. Consequently, the existence of an invalidity action in a national court should not prevent the use of the UPC for an infringement action.

In any event, Article 83 deals with the specific opt‐out context. But what about the more general context, namely the impact of an existing action before a national court, where no opt‐out has been requested?

Furthermore, what is the impact of actions before national courts pending at the time of the UPC inception?

These uncertainties make it difficult for parties to implement a defensive strategy. Is it worth investing in an invalidity action in a national court, before entry into force of the UPC? Assuming such an action impacts patentees' choices at all, will it completely prevent the use of the UPC or only preclude the use of the UPC for a nullity action?

Canonici

Jean‐Jacques Canonici


Gevers & OresHolidaystraat, 5B-1831 Diegem - BrusselsBelgiumTel: +32 2 715 37 11Fax: +32 2 715 37 00www.gevers.eu

more from across site and SHARED ros bottom lb

More from across our site

Sources explain why return-to-office mandates could hamper efficiency at the USPTO
The Unified Patent Court surpassing 700 cases and a row between Apple and PanOptis were among the top talking points this week
Partners at four firms explain how they help clients join in the hype around the big game without attracting the NFL’s wrath
We discuss how law firms are using AI, whether remote working has resulted in cost-savings, and what corporate counsel want from their advisers when it comes to DEI
Matthew Yeates, managing director at Integrated IP, discusses its acquisition of Clark IP and reveals further expansion plans
Paul Lee discusses moving from venture capital to IP, why lawyers are becoming more receptive to tech, and why he starts his day with a cold plunge
Barbara Lawton, a counsellor and mental health trainer at wellbeing charity Jonathan’s Voice, outlines tips for engaging with vulnerable people
New partner Amir Ghavi, who will help launch the group, says he expects more lateral hires in the coming weeks
Counsel at three firms reveal the tools they’re using to generate patent invalidity claim charts and why they’re making investments in the technology
Eric Lee says the firm’s thought leadership on artificial intelligence convinced him to move
Gift this article